Walleye Trading LLC - BIOCRYST PHARMACEUTICALS INC ownership

BIOCRYST PHARMACEUTICALS INC's ticker is BCRX and the CUSIP is 09058V103. A total of 199 filers reported holding BIOCRYST PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.63 and the average weighting 0.1%.

Quarter-by-quarter ownership
Walleye Trading LLC ownership history of BIOCRYST PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$517,236
+267.5%
73,056
+265.5%
0.00%
Q2 2023$140,730
-38.4%
19,990
-27.0%
0.00%
Q1 2023$228,516
-92.4%
27,400
-89.6%
0.00%
-100.0%
Q4 2022$3,014,705
+66.8%
262,605
+83.1%
0.01%
+60.0%
Q3 2022$1,807,000
+678.9%
143,389
+554.1%
0.01%
Q2 2022$232,000
-65.9%
21,920
-47.7%
0.00%
-100.0%
Q1 2022$681,000
-83.1%
41,932
-85.5%
0.00%
-84.6%
Q4 2021$4,019,000
-57.9%
290,122
-56.4%
0.01%
-60.6%
Q3 2021$9,553,000
+4.2%
664,803
+14.6%
0.03%
-8.3%
Q2 2021$9,171,000
+4049.8%
580,097
+1861.6%
0.04%
+3500.0%
Q4 2020$221,000
+163.1%
29,572
-29.7%
0.00%0.0%
Q1 2020$84,000
-46.2%
42,086
-6.7%
0.00%0.0%
Q4 2019$156,000
+1633.3%
45,086
+3521.4%
0.00%
Q3 2018$9,000
-97.2%
1,245
-96.7%
0.00%
-100.0%
Q1 2017$317,000
+1409.5%
37,700
+1785.0%
0.00%
Q4 2015$21,000
-48.8%
2,000
-44.4%
0.00%
Q3 2015$41,000
+485.7%
3,600
+620.0%
0.00%
Q2 2015$7,0005000.00%
Other shareholders
BIOCRYST PHARMACEUTICALS INC shareholders Q3 2021
NameSharesValueWeighting ↓
DG Capital Management, LLC 1,186,726$4,076,0002.45%
Sarissa Capital Management LP 4,861,000$16,697,0001.97%
Ghost Tree Capital, LLC 1,950,000$6,698,0001.94%
ORACLE INVESTMENT MANAGEMENT INC 2,525,857$8,676,0001.14%
Eversept Partners, LP 1,143,211$3,926,9300.87%
DAFNA Capital Management LLC 749,051$2,573,0000.84%
KNOTT DAVID M 397,361$1,365,0000.80%
Parkman Healthcare Partners LLC 800,740$2,751,0000.73%
ACUTA CAPITAL PARTNERS, LLC 660,000$2,267,0000.62%
Formidable Asset Management, LLC 578,200$1,949,0000.57%
View complete list of BIOCRYST PHARMACEUTICALS INC shareholders